The Wnt serpentine receptor frizzled-9 regulates new bone formation in fracture healing

PLoS ONE

Volumn 8, Issue 12, 2013, Pages

  Heilmann, Aline ^a   Schinke, Thorsten ^b   Bindl, Ronny ^a   Wehner, Tim ^a   Rapp, Anna ^a   Haffner Luntzer, Melanie ^a   Nemitz, Claudia ^a   Liedert, Astrid ^a   Amling, Michael ^b   Ignatius, Anita ^a  

^a UNIVERSITY OF ULM   (Germany)

^b UNIVERSITY MEDICAL CENTER HAMBURG EPPENDORF   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

ANIMALS; BIOMECHANICAL PHENOMENA; BONY CALLUS; FRACTURE HEALING; HISTOLOGICAL TECHNIQUES; MICE; OSTEOGENESIS; RECEPTORS, NEUROTRANSMITTER; STATISTICS, NONPARAMETRIC; WNT SIGNALING PATHWAY; X-RAY MICROTOMOGRAPHY;

EID: 84894109737     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0084232     Document Type: Article

References (47)

1. Harada S, Rodan GA (2003) Control of osteoblast function and regulation of bone mass. Nature 423: 349-355. (Pubitemid 40852710)
2. Rachner TD, Khosla S, Hofbauer LC (2011) Osteoporosis: now and the future. Lancet 377: 1276-1287.
3. Baron R, Kneissel M (2013) WNT signaling in bone homeostasis and disease: from human mutations to treatments. Nat Med 19: 179-192.
4. Macsai CE, Foster BK, Xian CJ (2008) Roles of Wnt signalling in bone growth, remodelling, skeletal disorders and fracture repair. J Cell Physiol 215: 578-587. (Pubitemid 351632678)
5. Kim JH, Liu X, Wang J, Chen X, Zhang H, et al. (2013) Wnt signaling in bone formation and its therapeutic potential for bone diseases. Ther Adv Musculoskelet Dis 5: 13-31.
6. Gong Y, Slee RB, Fukai N, Rawadi G, Roman-Roman S, et al. (2001) LDL receptor-related protein 5 (LRP5) affects bone accrual and eye development. Cell 107: 513-523. (Pubitemid 33152786)
7. Little RD, Carulli JP, Del Mastro RG, Dupuis J, Osborne M, et al. (2002) A mutation in the LDL receptor-related protein 5 gene results in the autosomal dominant high-bone-mass trait. Am J Hum Genet 70: 11-19. (Pubitemid 34031693)
8. Boyden LM, Mao J, Belsky J, Mitzner L, Farhi A, et al. (2002) High bone density due to a mutation in LDL-receptor-related protein 5. N Engl J Med 346: 1513-1521. (Pubitemid 34755690)
9. Richards JB, Rivadeneira F, Inouye M, Pastinen TM, Soranzo N, et al. (2008) Bone mineral density, osteoporosis, and osteoporotic fractures: a genome-wide association study. Lancet 371: 1505-1512.
10. Semenov MV, He X (2006) LRP5 mutations linked to high bone mass diseases cause reduced LRP5 binding and inhibition by SOST. J Biol Chem 281: 38276-38284. (Pubitemid 46043307)
11. Balemans W, Ebeling M, Patel N, Van Hul E, Olson P, et al. (2001) Increased bone density in sclerosteosis is due to the deficiency of a novel secreted protein (SOST). Hum Mol Genet 10: 537-543. (Pubitemid 32184286)
12. Claes L, Recknagel S, Ignatius A (2012) Fracture healing under healthy and inflammatory conditions. Nat Rev Rheumatol 8: 133-143.
13. Gerstenfeld LC, Cullinane DM, Barnes GL, Graves DT, Einhorn TA (2003) Fracture healing as a post-natal developmental process: molecular, spatial, and temporal aspects of its regulation. J Cell Biochem 88: 873-884. (Pubitemid 36337032)
14. Caetano-Lopes J, Lopes A, Rodrigues A, Fernandes D, Perpetuo IP, et al. (2011) Upregulation of inflammatory genes and downregulation of sclerostin gene expression are key elements in the early phase of fragility fracture healing. PLoS One 6: e16947.
15. Chen Y, Whetstone HC, Lin AC, Nadesan P, Wei Q, et al. (2007) Beta-catenin signaling plays a disparate role in different phases of fracture repair: implications for therapy to improve bone healing. PLoS Med 4: e249.
16. Dean DB, Watson JT, Jin W, Peters C, Enders JT, et al. (2010) Distinct functionalities of bone morphogenetic protein antagonists during fracture healing in mice. J Anat 216: 625-630.
17. Zhong N, Gersch RP, Hadjiargyrou M (2006) Wnt signaling activation during bone regeneration and the role of Dishevelled in chondrocyte proliferation and differentiation. Bone 39: 5-16. (Pubitemid 43831768)
18. Hadjiargyrou M, Lombardo F, Zhao S, Ahrens W, Joo J, et al. (2002) Transcriptional profiling of bone regeneration. Insight into the molecular complexity of wound repair. J Biol Chem 277: 30177-30182.
19. Minear S, Leucht P, Jiang J, Liu B, Zeng A, et al. (2010) Wnt proteins promote bone regeneration. Science translational medicine 2: 29ra30.
20. Agholme F, Aspenberg P (2011) Wnt signaling and orthopedics, an overview. Acta Orthop 82: 125-130.
21. Jawad MU, Fritton KE, Ma T, Ren PG, Goodman SB, et al. (2013) Effects of sclerostin antibody on healing of a non-critical size femoral bone defect. J Orthop Res 31: 155-163.
22. Ominsky MS, Li C, Li X, Tan HL, Lee E, et al. (2011) Inhibition of sclerostin by monoclonal antibody enhances bone healing and improves bone density and strength of nonfractured bones. J Bone Miner Res 26: 1012-1021.
23. Agholme F, Li X, Isaksson H, Ke HZ, Aspenberg P (2010) Sclerostin antibody treatment enhances metaphyseal bone healing in rats. J Bone Miner Res 25: 2412-2418.
24. Kim JB, Leucht P, Lam K, Luppen C, Ten Berge D, et al. (2007) Bone regeneration is regulated by wnt signaling. J Bone Miner Res 22: 1913-1923. (Pubitemid 351229308)
25. Komatsu DE, Mary MN, Schroeder RJ, Robling AG, Turner CH, et al. (2010) Modulation of Wnt signaling influences fracture repair. J Orthop Res 28: 928-936.
26. Baron R, Hesse E (2012) Update on bone anabolics in osteoporosis treatment: rationale, current status, and perspectives. The Journal of clinical endocrinology and metabolism 97: 311-325.
27. Imming P, Sinning C, Meyer A (2006) Drugs, their targets and the nature and number of drug targets. Nature reviews Drug discovery 5: 821-834. (Pubitemid 44480536)
28. Albers J, Schulze J, Beil FT, Gebauer M, Baranowsky A, et al. (2011) Control of bone formation by the serpentine receptor Frizzled-9. J Cell Biol 192: 1057-1072.
29. Pober BR (2010) Williams-Beuren syndrome. The New England journal of medicine 362: 239-252.
30. Schubert C (2009) The genomic basis of the Williams-Beuren syndrome. Cellular and molecular life sciences: CMLS 66: 1178-1197.
31. Cherniske EM, Carpenter TO, Klaiman C, Young E, Bregman J, et al. (2004) Multisystem study of 20 older adults with Williams syndrome. American journal of medical genetics Part A 131: 255-264.
32. Claes L, Blakytny R, Besse J, Bausewein C, Ignatius A, et al. (2011) Late dynamization by reduced fixation stiffness enhances fracture healing in a rat femoral osteotomy model. J Orthop Trauma 25: 169-174.
33. Zhao C, Denison C, Huibregtse JM, Gygi S, Krug RM (2005) Human ISG15 conjugation targets both IFN-induced and constitutively expressed proteins functioning in diverse cellular pathways. Proc Natl Acad Sci U S A 102: 10200-10205. (Pubitemid 41023349)
34. Rauner M, Stein N, Winzer M, Goettsch C, Zwerina J, et al. (2012) WNT5A is induced by inflammatory mediators in bone marrow stromal cells and regulates cytokine and chemokine production. J Bone Miner Res 27: 575-585.
35. Wintges K, Beil FT, Albers J, Jeschke A, Schweizer M, et al. (2013) Impaired bone formation and increased osteoclastogenesis in mice lacking chemokine (C-C motif) ligand 5 (Ccl5). J Bone Miner Res 28: 2070-2080.
36. Binder NB, Niederreiter B, Hoffmann O, Stange R, Pap T, et al. (2009) Estrogen-dependent and C-C chemokine receptor-2-dependent pathways determine osteoclast behavior in osteoporosis. Nat Med 15: 417-424.
37. Alblowi J, Tian C, Siqueira MF, Kayal RA, McKenzie E, et al. (2013) Chemokine expression is upregulated in chondrocytes in diabetic fracture healing. Bone 53: 294-300.
38. Kakar S, Einhorn TA, Vora S, Miara LJ, Hon G, et al. (2007) Enhanced chondrogenesis and Wnt signaling in PTH-treated fractures. J Bone Miner Res 22: 1903-1912. (Pubitemid 351229307)
39. Chun JS, Oh H, Yang S, Park M (2008) Wnt signaling in cartilage development and degeneration. BMB Rep 41: 485-494.
40. Yates KE, Shortkroff S, Reish RG (2005) Wnt influence on chondrocyte differentiation and cartilage function. DNA Cell Biol 24: 446-457. (Pubitemid 40994556)
41. Huang Y, Zhang X, Du K, Yang F, Shi Y, et al. (2011) Inhibition of beta-catenin signaling in chondrocytes induces delayed fracture healing in mice. J Orthop Res 30: 304-310.
42. Glass DA 2nd, Bialek P, Ahn JD, Starbuck M, Patel MS, et al. (2005) Canonical Wnt signaling in differentiated osteoblasts controls osteoclast differentiation. Dev Cell 8: 751-764. (Pubitemid 40585297)
43. Holmen SL, Zylstra CR, Mukherjee A, Sigler RE, Faugere MC, et al. (2005) Essential role of beta-catenin in postnatal bone acquisition. J Biol Chem 280: 21162-21168. (Pubitemid 40805677)
44. Kramer I, Halleux C, Keller H, Pegurri M, Gooi JH, et al. (2010) Osteocyte Wnt/beta-catenin signaling is required for normal bone homeostasis. Molecular and cellular biology 30: 3071-3085.
45. Röntgen V, Blakytny R, Matthys R, Landauer M, Wehner T, et al. (2010) Fracture healing in mice under controlled rigid and flexible conditions using an adjustable external fixator. J Orthop Res 28: 1456-1462.
46. Morgan EF, Mason ZD, Chien KB, Pfeiffer AJ, Barnes GL, et al. (2009) Microcomputed tomography assessment of fracture healing: relationships among callus structure, composition, and mechanical function. Bone 44: 335-344.
47. Heilmann A, Schinke T, Bindl R, Wehner T, Rapp A, et al. (2013) Systemic treatment with the sphingosine-1-phosphate analog FTY720 does not improve fracture healing in mice. J Orthop Res 31: 1845-1850.